Myocardial infarction in the population of some Russian regions and its prognostic value

Aim. To study the prevalence of myocardial infarction (MI) in the population of Russian regions and its contribution to cardiovascular events.

Material and methods. The analysis material was representative samples of the population aged 35-64 years from 11 Russian regions,  examined within the multicenter study “Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions  of Russian Federation”. The response rate was about 80%. The study used a community-based  systematic stratified multiply random sample. During the study, information on prior MI was obtained using a standard questionnaire. Anthropometry and measurement of blood pressure (BP) and heart rate (HR) with an automatic BP monitor were performed. Resting electrocardiography (ECG) was performed, followed by Minnesota coding. Major and minor QQS waves and STT segments were considered as ischemic  ECG abnormalities. Biochemical parameters were determined using an Arkhitect 000 Clinical Chemistry Analyzer. The median prospective  follow-up was 6,21 [5,25; 6,75] years. A composite endpoint (CE) was analyzed, including cardiovascular death and non-fatal MI. During the follow-up period, 363 all-cause deaths were detected,  of which 134 were from cardiovascular diseases, while 196 — CEs. Statistical analysis was carried out in R 3.6.1 environment.

Results. The MI prevalence among the Russian population was 2,9%; 5,2% for men and 1,5% for women,  increasing  with age. Men with prior MI were  more likely to take statins and beta-blockers  than women as follows: 39,0% vs 25,6% and 29,3% vs 27,1%, respectively. MI newly diagnosed within the follow-up  period was associated with the following risk factors (RFs): smoking, increased BP, HR, triglycerides and glucose.  For individuals with prior MI, a significant relationship was found only with smoking.  Multiple comparison  of the contribution of RFs, ECG abnormalities,  and prior MI showed  that the inclusion of ischemic ECG abnormalities in the analysis significantly increases  the risk of cardiovascular events in individuals without prior MI compared with individuals without both MI and ECG changes.  A high CE risk was noted in patients with prior MI: relative risk (RR), 4,73 (2,92-7,65); the addition of ischemic ECG abnormalities increased the RR to 5,75 (3,76-8,8).

Conclusion. The RR of CEs in patients  with prior MI without or with ischemic ECG changes  is 4,73 and 5,75 times higher than in patients without MI and ECG abnormalities. The risk factors  identified  in this case cannot explain such an increase  in CEs. It is obvious  that people  with prior MI need  rehabilitation. The presence of RFs in patients with newly diagnosed  MI indicates insufficient primary prevention, which suggests  that strengthening preventive measures to eliminate conventional risk factors in patients with newly diagnosed  MI will help reduce the risk of recurrent MI or cardiovascular  mortality.

1. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics — 2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254-e743. doi:10.1161/CIR.0000000000000950.

2. Hashim MJ. Principles of family medicine and general practice-defining the five core values of the specialty. J Prim Health Care. 2016;8:283-7. doi:10.1071/HC16006.

3. Nowbar AN, Gitto M, Howard JP, et al. Mortality from ischemic heart disease: analysis of data from the World Health Organization and coronary artery disease risk factors from NCD Risk Factor Collaboration. Circ Cardiovasc Qual Outcomes. 2019;12:005375. doi:10.1161/CIRCOUTCOMES.118.005375.

4. Khan MA, Hashim MJ, Mustafa H, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020;12(7):e9349. doi:10.7759/cureus.9349.

5. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association. Circulation. 2011;123(8):933-44. doi:10.1161/CIR.0b013e31820a55f5.

6. Greenlee RT, Naleway AL, Vidaillet H. Incidence of myocardial infarction in a general population: the Marshfield Epidemiologic Study Area. WMJ. 2002;101(7):46-52.

7. Thygesen K, Alpert JS, Jaffe AS, et al. ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237-69. doi:10.1093/eurheartj/ehy462.

8. Akimova EV, Gafarov VV, Trubacheva IA, et al. Coronary heart disease in Siberia: interpopulation differences. Sibirsky Meditsinsky Zhurnal. 2011;26(3),1:153-7. (In Russ.)

9. Piwońska A, Piwoński J, Szcześniewska D, et al. Population prevalence of electrocardiographic abnormalities: results of the Polish WAWKARD study. Kardiol Pol. 2019;77(9):859-67. doi:10.33963/KP.14911.

10. Prokhoda VA. Assessment of the national health care system by residents of Russia and other European countries. Politics and Society. 2018;10:65-77. (In Russ.) doi:10.7256/2454-0684.2018.10.27654.

11. Dawber TR, Meadors GF, Moore Jr FE. Epidemiological approaches to heart disease: the Framingham Study. Am J Pub Health. 1951;41:279-86. doi:10.2105/ajph.41.3.279.

12. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol. 1976;37(2):269-82. doi:10.1016/0002-9149(76)90323-4.

13. Kish L. A procedure for objective respondent within households in phone surveys. J. Am. Statistical association. 1949;247:380-7.

14. Prineas RJ, Crow RS, Zhang ZM. The Minnesota Code Manual of Electrocardiographic Findings (Including Measurement and Comparison with the Novacode: Standards and Procedures for Measurement in Epidemiologic and Clinical Trials). 2nd. Springer; London. 2009:277-324. ISBN 978-1-84882-777-6. e-ISBN 978-1-84882-778-3. doi:10.1007/978-1-84882-778-3.

15. Boytsov SA, Chazov EI, Shlyakhto EV, et al. Scientific and the organizing Committee of the ESSERF. Epidemiology of cardiovascular diseases in different regions of Russia (ESSERF), rationale and study design. Profilakticheskaya Medicina. 2013;16(6):25-34. (In Russ.)

16. Kotova EG, Kobyakova OS, Starodubov VI, et al. Morbidity of the adult population of Russia in 2020 with a diagnosis established for the first time in life: statistical materials. M.: RIH (Russian research Institute of Health) of the Ministry of Health of Russia. 2021;164 р. (In Russ.)

17. Denes P, Daniel B, Garside DB, et al. Major and Minor Electrocardiographic Abnormalities and their Association with Underlying Cardiovascular Disease and Risk Factors in Hispanics/Latinos (From the Hispanic Community Health Study/ Study of Latinos [HCHS/SOL]). Am J Cardiol. 2013;112(10):1667-75. doi:10.1016/j.amjcard.2013.08.004.

18. Pinto-Filho MM, Brant LCC, Foppa M, et al. Major Electrocardiographic Abnormalities According to the Minnesota Coding System Among Brazilian Adults (from the ELSA-Brasil Cohort Study). Am J Cardiol. 2017;119:2081e2087. doi:10.1016/j.amjcard.2017.03.043.

19. Silva M, Palhares D, Ribeiro L, et al. Prevalence of major and minor electrocardiographic abnormalities in one million primary care Latinos. J Electrocardiol. 2021;64:36-41. doi:10.1016/j.jelectrocard.2020.11.013.

20. Jayaraj JC, Davatyan K, Subramanian S, et al. Epidemiology of Myocardial Infarction. In. Pamukçu B. (ed.), Myocardial Infarction, IntechOpen, London 2018. doi:10.5772/intechopen.74768.

21. Hinton W, McGovern A, Coyle R, et al. Incidence and prevalence of cardiovascular disease in English primary care: a cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC). BMJ Open. 2018;8:e020282. doi:10.1136/bmjopen-2017-020282.

22. Ametov AS, Orlov VA, Zhestovsky SS. Features of painless myocardial ischemia in patients with non-insulin-dependent diabetes mellitus. The experience of using persantin. Problems of Endocrinology. 1997;43(4):9-12. (In Russ.) doi:10.14341/probl19974349-12.

23. Tamosiunas A, Petkeviciene J, Radisauskas R, et al. Trends in electrocardiographic abnormalities and risk of cardiovascular mortality in Lithuania, 1986–2015. BMC Cardiovascular Disorders. 2019;19:30. doi:10.1186/s12872-019-1009-3.

24. Davidovich IM, Malai LN, Kutishenko NP. Long-term results and adherence to therapy in patients who have suffered acute myocardial infarction: registry data (Khabarovsk). Clinician. 2016/2017; 10/11(4):36-44. (In Russ.) doi:10.17650/1818-8338-2016-10-4-36-44.

25. Martsevich SYu, Kutishenko NP, Sichinava DP, et al. Prospective outpatient registry of myocardial infarction patients (PROFILE-MI): study design and first results. Cardiovascular Therapy and Prevention. 2018;17(1):81-6. (In Russ.) doi:10.15829/1728-8800-2018-1-81-86.